
Meridian Bioscience VIVO
Quarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience P/B Ratio 2011-2026 | VIVO
Annual P/B Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.92 | 1.92 | 1.9 | 2.17 | 3.88 | 3.49 | 3.79 | 4.2 | 4.02 | 5.36 | 4.47 | 4.07 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.36 | 1.9 | 3.52 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
RadNet
RDNT
|
4.15 | $ 56.78 | -4.44 % | $ 4.27 B | ||
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Soleno Therapeutics
SLNO
|
4.63 | $ 30.52 | -4.12 % | $ 1.55 B | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Neuronetics
STIM
|
3.09 | $ 1.4 | 4.89 % | $ 92.3 M | ||
|
Sotera Health Company
SHC
|
7.84 | $ 13.26 | -2.1 % | $ 3.77 B | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Biodesix
BDSX
|
4.41 | $ 14.18 | -2.91 % | $ 1.84 B | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
0.179 | $ 1.16 | 0.87 % | $ 6.32 M | ||
|
Trinity Biotech plc
TRIB
|
-375 | $ 0.6 | -2.18 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | - | - | $ 2.68 B | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 23.99 | -2.87 % | $ 666 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 158.77 | -3.85 % | $ 7.87 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 195.86 | -1.16 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
0.296 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.24 | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
0.298 | $ 8.45 | - | $ 33.7 M | ||
|
Waters Corporation
WAT
|
7.68 | $ 290.62 | -3.31 % | $ 17.3 B | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
1.85 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
-1.86 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
IQVIA Holdings
IQV
|
4.27 | $ 164.81 | -2.71 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 8.79 | -3.93 % | $ 1.91 B | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
1.25 | $ 6.41 | -12.43 % | $ 380 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 266.15 | -0.83 % | $ 22.1 B | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 6.45 | -1.68 % | $ 269 M | ||
|
Psychemedics Corporation
PMD
|
2.52 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
0.603 | $ 25.64 | -5.75 % | $ 33.3 M | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 16.82 | -3.72 % | $ 896 M | ||
|
Quotient Limited
QTNT
|
-5.15 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
2.74 | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
-2.89 | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
-2.1 | $ 0.2 | 1.08 % | $ 19.2 M |